Literature DB >> 27178083

Announcing the CDC guideline for prescribing opioids for chronic pain.

Debra Houry1, Grant Baldwin2.   

Abstract

This guideline provides recommendations for primary care providers who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses: (a) when to initiate or continue opioids for chronic pain; (b) opioid selection, dosage, duration, follow-up, and discontinuation; and (c) assessing risk and addressing harms of opioid use. This guideline is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including abuse, dependence, overdose, and death (Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep 2016;65:1-49. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1.).
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Chronic pain; Opioids; Prescription drug

Mesh:

Substances:

Year:  2016        PMID: 27178083     DOI: 10.1016/j.jsr.2016.03.007

Source DB:  PubMed          Journal:  J Safety Res        ISSN: 0022-4375


  3 in total

1.  Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018.

Authors:  Lauren R Gorfinkel; Deborah Hasin; Andrew J Saxon; Melanie Wall; Silvia S Martins; Magdalena Cerdá; Katherine Keyes; David S Fink; Salomeh Keyhani; Charles C Maynard; Mark Olfson
Journal:  J Pain       Date:  2022-02-08       Impact factor: 5.383

2.  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.

Authors:  Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 9.308

3.  Post-operative opioid pain management patterns for patients who receive hip surgery.

Authors:  Chad E Cook; Daniel I Rhon; Brian D Lewis; Steven Z George
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.